This course will cover causative factors in congenital and early-onset forms of glaucoma, in order to prevent vision loss and legal blindness later in life in this young population.
Optometry | OD
Pacific University offers a four-year doctor of optometry program preparing tomorrow's optometrists for licensure and practice.
The curriculum consists of academic and laboratory experiences integrated with clinical work. The fourth year is entirely clinical, consisting of four full-time preceptorships.
In addition to clinical training, Pacific demonstrates its commitment to quality optometric research by offering all students an elective research thesis opportunity, encouraging and providing funds for faculty to attend scientific meetings and providing research facilities. The annual Pacific Vision Conference on campus allows practitioners, students, faculty and other researchers the opportunity to exchange findings and information.
Pacific University graduates are fully qualified to practice in any state in the nation, the curriculum far exceeding the most stringent educational requirements of any state. The curriculum also prepares students for successful completion of the National Board Exam.
In March 2014, our Class of 2015 first-time pass rate on the Applied Basic Science (ABS) exam was 88.5 percent, compared to the 77.56 percent national average. Pacific’s scores are typically above the national average, and reflect the elite education our students receive here at Pacific University, and the hard work, dedication and focus our students and faculty bring to the classroom every day.
|OPT-500||Basic Science for Optometry with Laboratory||2.5|
|OPT-501||Geometric and Physical Optics I with Laboratory||3.0|
|OPT-516||Patient Care I||.5|
|OPT-532||Anatomy of the Visual System with Laboratory||3.0|
|OPT-535||Functional Neuroanatomy and Neurobiology||3.0|
|OPT-540||Essentials of Medical Pharmacology I||1.0|
|OPT-546||Clinical Procedures I with Laboratory||2.5|
|OPT-562||Behavioral Optometric Science with Laboratory||4.0|
|OPT-568||Practice Management I||1.0|
|OPT-502||Geometric and Physical Optics II with Laboratory||3.0|
|OPT-503||Physiological Optics I with Laboratory||4.0|
|OPT-517||Patient Care II||.5|
|OPT-531||Ocular Anatomy, Physiology and Biochemistry with Lab||3.0|
|OPT-533||Ocular Disease I with Laboratory||3.0|
|OPT-537||Systemic Diseases and Medications I||3.0|
|OPT-541||Essentials of Medical Pharmacology II||1.0|
|OPT-547||Clinical Procedures II with Laboratory||2.5|
|OPT-560||Evidence Based Optometry||1.0|
|OPT-616||Theory and Methods of Refraction||3.0|
|OPT-620||Patient Care III||.5|
|OPT-631||Ocular Disease II with Laboratory||3.0|
|OPT-637||Systemic Diseases and Medications II||3.0|
|OPT-640||Essentials of Medical Pharmacology III||
|OPT-646||Clinical Procedures III with Laboratory||2.0|
|OPT-647||Ophthalmic Dispensing Procedures with Lab||2.0|
|OPT-662||Visual Information Processing and Perception||4.0|
|OPT-668||Practice Management III||1.0|
|OPT-615||Vision Therapy for Binocular and Oculomotor Dysfunction with Lab||4.0|
|OPT-617||Optometric Case Analysis||4.0|
|OPT-618||Theory and Practice of Spherical Rigid and Soft Contact Lenses with Lab||3.0|
|OPT-621||Patient Care IV||.5|
|OPT-633||Ocular Disease III with Lab||4.0|
|OPT-638||Systemic Diseases and Medications III||2.0|
|OPT-648||Clinical Procedures IV with Lab||4.0|
|Summer (14 weeks)||Credits|
|OPT-701||Physiological Optics II||3.0|
|OPT-703||Patient Care Seminar I||.5|
|OPT-714||Pediatric and Developmental Optometry||3.0|
|OPT-715||Patient Care V||1.5|
|OPT-7XX||Specialty Patient Care**||1.5|
|OPT-716||Theory and Practice of Specialty Contact Lenses with Lab||3.5|
|OPT-768||Practice Management III||1.0|
|OPT-704||Patient Care Seminar II||.5|
|OPT-718||Advanced Optometric Case Analysis with Lab||2.0|
|OPT-722||Patient Care VI||1.5|
|OPT-7XX||Specialty Patient Care**||1.5|
|OPT-725||Assessment and Management of Strabismus and Amblyopia with Lab||4.0|
|OPT-728||Assessment and Management of the Partially Sighted Patient||2.0|
|OPT-733||Ocular Disease IV with Laboratory||3.0|
|OPT-762||Communication in Optometric Practice with lab||2.0|
|OPT-705||Patient Care Seminar III||.5|
|OPT-723||Patient Care VII||1.5|
|OPT-7XX||Specialty Patient Care**||1.5|
|OPT-727||Evaluation and Management of Patients with Perceptual Problems with Lab||2.0|
|OPT-735||Applied Ocular Therapeutics||1.0|
|OPT-461||Public Health Optometry||2.0|
|OPT-763||Environmental, Occupational and Recreational Vision||2.0|
|OPT-769||Practice Management IGV||1.0|
*Students are required to take at least three credits of electives.
** Students will rotate through each Specialty Patient Care (OPT-770: Pediatric/Binocular Vision, OPT-771: Contact Lens, OPT-772: Ocular Disease and Specialty Testing and Low Vision) through the third year.
*** Students are required to take one semester of OPT-736, either fall or spring
|OPT-806*||Patient Care VIII|
|OPT-807*||Patient Care IX|
|OPT-808*||Patient Care X|
|OPT-809*||Patient Care XI|
|OPT-827||Web-Based Clinical Rounds|
Interns will provide supervised and direct patient care in various specialty tracks within Pacific University affiliated eye and vision care centers (Tracks 1-4) or in affiliated hospital settings, healthcare centers, and public or private eye and vision care centers. Primary care and/or specialized healthcare services unique to each site (Track 5).
Track 1: Ocular Disease with Emphasis in Contact Lens | Rotation in the ocular disease and special testing and contact lens specialty clinics, including the clinical assessment and management of patients with ocular diseases, and management of cosmetic and therapeutic specialty contact lens prescribing.
Track 2: Ocular Disease with Emphasis in Low Vision | Rotation in the ocular disease and special testing and low vision specialty clinics, including the clinical assessment and management of patients with ocular diseases, and management of patients with low vision rehabilitation needs. Rotation also includes a half-day of contact lens service per week.
Track 3: Vision Therapy, Pediatrics, Neuro-Optometry | Rotation in the binocular vision/vision therapy and pediatric clinics including supervised clinical management of patients requiring vision therapy. Weekly experience in the Pediatric and Strabismus Referral Center (PSRC) and neuro-optometry services with related exposure to co-management principles. Rotation also includes a half day of contact lens service per week.
Track 4: Vision Therapy and Pediatrics | Rotation in the binocular vision/vision therapy and pediatric clinics including supervised clinical management of patients requiring vision therapy. Unique exposure in the Beaverton 3D Performance Clinic.
Track 5 | Supervised clinical practice in affiliated hospital settings, healthcare centers, and public or private eye and vision care centers. Primary care and/or specialized healthcare services unique to each site.
Critical to clinicians is the ability to diagnose and manage unique and interesting presentations of typical ocular conditions, or to be able to diagnose a previously un-encountered condition. The following course will present patient cases with unique presentations of ocular conditions, including special testing. The course will focus on the ability of the clinician to analyze and interpret the unique case presentation and provide appropriate management and treatment options.
This course presents the diagnosis, differential diagnosis, and treatment of optic nerve head drusen, iron-deficiency anemia, and Laurence-Moon/Bardet-Biedl Syndrome in three young patients
This course covers how to diagnose eye muscle palsies and how to treat them with prism. Both congenital and acquired strabismic causes of diplopia and near-diplopia are covered, as well as prism prescribing techniques called associated phorometry.
This course will cover causes of monocular vision loss in young patients, including congenital cataract, retinoblastoma tumors of the eye and brain, and genetic conditions that can threaten both sight and, sometimes, the life of the patient.
Over the past year, a number of new developments have been made in the understanding and management of age-related macular degeneration (AMD). This course will present an overview of our current knowledge about AMD focusing on the prevalence, pathogenesis, genetics, prevention and treatment, now and in the pipeline.
This course will cover diagnosis and treatment of both arteritic and non-arteritic ischemic optic neuropathy (NAION), or stroke of the optic nerve.
The scope of practice in optometry continues to expand over the years. Most optometrists can prescribe topical and non-topical medications. This course presents drugs pertinent to optometrists with box warnings of potentially serious adverse effects.
This course will take a systematic approach to managing unique ammetropia’s, certain disease states, and post-surgical outcomes with contact lenses for successful visual and physiologic result. Case's histories will be presented that demonstrate the use and integration of contact lenses in management of the patient.
Cytogmegalovirus retinitis (CMVR) is a condition affecting primarily HIV/ AIDS infected individuals. A rare case of a patient with CMVR whose presenting complaint was itchy eyes is presented, emphasizing the need for routine dilation.
This course focuses on the clinical diagnosis and management of episcleritis. It covers the clinical features of episcleritis as compared to scleritis and other red eye conditions. Additionally, supportive and medical therapy are presented.
This course will cover differential diagnosis of optic nerve disorders, including optic atrophy, hypoplasia, colobomas, tilted discs, intercranial hypertension, AION, optic disc drusen and neuritis, non-glaucomatous neuropathy, and optic nerve tumors, among others.
This course covers the ocular and visual manifestations of Ehlers-Danlos syndrome, perhaps the most common of the connective tissue disorders, including optometric diagnosis and treatment.
This course describes the applications of electroretinography (ERG) and visually-evoked potential (VEP) in primary eye care. Included are data acquisition from ERG and VEP, diagnosis, and differential diagnoses from these tests.
Evaluating the anterior chamber angle with gonioscopy is an essential part of evaluating patients at risk for glaucoma and neovascularization. It is also useful for patients with iris abnormalities or a history of trauma or ocular inflammation. Unfortunately, gonioscopy is underutilized by both optometrists and ophthalmologists. Coleman, et al. found that less than half of Medicare beneficiaries underwent gonioscopy during a 4-5 year period prior to glaucoma surgery. It is critical to our patient’s ocular health that this change.
This article discusses the indications and contraindications to performing gonioscopy.
Anterior chamber angle anatomy, types of gonioscopy lenses, a review of the procedure, and proper recording and insurance coding will also be covered. Finally, we will describe common variations of normal anterior chamber angles and angle abnormalities that are commonly seen in an eye care setting.
If you think you have seen dramatic technological changes in the last five years, just watch the next five!
Regarding the access to an incredible amount of genetic information, it has been said that “even if we do not know and do not want to know, we now know that we can know… choosing not to know can be as heavy a burden as choosing to know."
This course educates the optometrist as to the causes and consequences, both systemic and ocular, of HIV infection and Acquired Immunodeficiency Syndrome, or AIDS.
The following interactive course will focus on OCT interpretation using clinical cases. It will provide an overview of interpretation and diagnostics in retina and glaucoma management using OCT and perimetry. Structure and function will be discussed in detail.
This course serves to provide a background and clinical application of MSI for the optometrist.Fundus evaluation technology has evolved exponentially over the last 150 years. Along with standard full-spectrum fundus photography, angiography, scanning laser polarimetry , and optical coherence tomography, multispectral imaging (MSI) shows great promise for enhanced evaluation of the fundus. This course serves to provide a background and clinical application of MSI for the optometrist
This course will cover micronutrient and macronutrient deficiency and excess that lead to preservation or loss of sight, particularly in older patients.
Over the past few years a number of new developments have been made in the understanding and treatment of common ocular diseases. This course will present an update on a few new drugs in the treatment of macular degeneration and glaucoma and share some of the latest progress in treatment of macular degeneration (AMD). Furthermore, it will provide research findings on potential novel application of ophthalmic drugs for management of ocular surface disease such as dry eye and pterygium.
Optometrists see patients presenting with eye pain on an almost daily basis. They are challenging to manage because the eyes and orbit are heavily innervated, so there are many causes that can lead to ocular discomfort. The most challenging cases of eye pain are those presenting with a quiet-appearing eye. Undiagnosed, misdiagnosed and mismanagement of some of these conditions can result in irreversible vision loss or systemic disability. This course focuses on 3 categories that can lead to ocular pain: 1) eye pain from an ocular or orbital source; 2) eye pain referred from a distant source; and 3) eye pain from other sources.
This course will teach diagnosis and treatment of optic disc drusen, idiopathic intercranial hypertensiion, papilledema, optic neuritis, stroke of the optic nerve, meningiomas and gliomas, Leber hereditory optic neuropathy, and trauma, and related conditions
This course is an overview of the literature in regards to physiological and pathological changes that can happen to the eye during pregnancy. Also discussed are treatment options for various ocular conditions that could occur in a pregnant patient. Please note that it is always encouraged to check with an obstetrician or primary care provider before initiating treatment of any kind.
This course focuses on the clinical diagnosis and management of scleritis. It covers the clinical features of scleritis as compared to episcleritis and other red eye conditions. Additionally, associated systemic conditions are discussed with relevant medical therapy.
Treatment and management of glaucoma continues to advance through increased pharmacological options and technological instrumentation. This course reviews current medicinal choices for treating glaucoma, as well as management protocols for testing and follow-up.
Plaquenil maculopathy is an uncommon side effect of the systemic medication, Hydroxychrloroquine. This lecture will guide the optometrist in diagnosis and management of laquenil maculopathy. The course will review updated guidelines from the American Academy of Ophthalmology and discuss exciting new research utilizing OCT.
This course will discuss the autoimmune disease Graves and it’s systemic and ocular manifestations, including pathogenesis, new lab blood tests, and interactions with smoking and mental health.Graves disease is a complex autoimmune disease that can affect the eye. New research has changed our understanding of Graves disease. This course translates the research into clinical practice. Through discussion of diagnosis, prognosis, treatment, and case examples, the clinician will be better able to manage patients with Graves disease.
The course is introduced with case presentations. Utilizing the cases, a review of basic science aspects of common congenital disorders is reviewed with both Down Syndrome and Smith-Magenis Syndrome being reviewed in detail. Ocular manifestations of these disorders is emphasized along with suggested optometric management.
Hypertension is the most common systemic disease for office visits to clinicians. Optometrists play an important role in diagnosing and managing various ocular complications secondary to hypertension. This course focuses to enhance that role.
Anti‐Vascular Endothelial Growth Factor (Anti-VEGF) medication line of medications and explained for primary eye care providers, and how they are used to treat a variety of ocular pathologies, with a realistic expectation of their limitations.
The course reviews the laws and statutes that govern the practice of optometry in the state of Oregon. The approval from the Oregon Board of Optometry for this course expires on January 1, 2015.
It is not uncommon for the optometrist to have patients presenting to the office with complaint of eye pain. Many ocular conditions can present with varying amounts of pain. Pain is highly subjective, and is dependent on the type and severity of ocular insult, the chronicity of the pain symptom, and the experiential and psychological background of the patient. As pain is subjective, the amount of pain for the same ocular insult can vary widely from patient to patient. For example, some patients may not express any pain for a corneal abrasion, while others may relay excruciating pain for a similar injury. Often a scale of 0 to 10 is asked by the optometrist to help them understand the amount of pain their patient is experiencing. Elucidating if the pain is “burning”, “stinging”, “sharp”, “dull”, “itching”, “throbbing”, may be of diagnostic use. Likewise, localizing if the pain is on the surface (i.e. the patient notices it with each blink) versus deeper (i.e. the patient feels a retrobulbar pain on eye movements) is also important diagnostically.
This course will cover the causes and treatments of uveitic glaucoma, including clogged, inflamed, and damaged trabecular meshwork, synechiae, and steroid response.
This course will prepare optometrists to diagnose types of cognitive impairment, including acute delirium, reversible and irreversible dementias, as well as effects of neuroses and psychoses, on the visual system.
It is hardly a profound statement to observe that women are different than men, and very frequently the differences makes it important for health care practitioners to be aware of health problems that occur more commonly in the female population. Awareness of the above will often lead to better and more appropriate care for the female patient.
There are many diseases and disorders which are quite commonly seen in female patients that are much less commonly seen in men, such as the autoimmune diseases, however, women live significantly longer than do men. Unfortunately for the female population, they do experience more illness and have more "sick time" than do men on average.
In no way is this presentation to be considered "exhaustive" on the subject of female health Issues. Rather, the following is a discussion of several diseases and disorders which are commonly diagnosed in the optometric practice and which occur more frequently in the female patient than in the male patient. This is particularly important as optometrists are recognized as independent health care practitioners and are quite often the doctor of first contact when symptoms lead to a doctor's office visit by the patient.